"In conclusion, we found that lopinavir–ritonavir treatment did NOT significantly accelerate clinical improvement, reduce mortality, or diminish throat viral RNA detectability in patients with serious Covid-19." March 18, 2020 nejm.org/doi/full/10.1056/NEJM

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.